Free Trial

Telesis Bio (TBIO) Competitors

Telesis Bio logo
$0.01 0.00 (0.00%)
As of 05/20/2025

TBIO vs. SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYS

Should you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry.

Telesis Bio vs.

Schmitt Industries (NASDAQ:SMIT) and Telesis Bio (NASDAQ:TBIO) are both small-cap industrials companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, community ranking, profitability, earnings, dividends and risk.

Schmitt Industries received 85 more outperform votes than Telesis Bio when rated by MarketBeat users. Likewise, 55.29% of users gave Schmitt Industries an outperform vote while only 52.94% of users gave Telesis Bio an outperform vote.

CompanyUnderperformOutperform
Schmitt IndustriesOutperform Votes
94
55.29%
Underperform Votes
76
44.71%
Telesis BioOutperform Votes
9
52.94%
Underperform Votes
8
47.06%

In the previous week, Schmitt Industries' average media sentiment score of 0.00 equaled Telesis Bio'saverage media sentiment score.

Company Overall Sentiment
Schmitt Industries Neutral
Telesis Bio Neutral

37.6% of Telesis Bio shares are held by institutional investors. 17.1% of Schmitt Industries shares are held by insiders. Comparatively, 24.5% of Telesis Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Schmitt Industries has higher earnings, but lower revenue than Telesis Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schmitt Industries$9.89M0.01-$3.28MN/AN/A
Telesis Bio$225.09M0.00-$47.72M-$28.200.00

Schmitt Industries has a beta of -0.31, suggesting that its share price is 131% less volatile than the S&P 500. Comparatively, Telesis Bio has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500.

Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company Net Margins Return on Equity Return on Assets
Schmitt IndustriesN/A N/A N/A
Telesis Bio -336.59%N/A -61.89%

Summary

Schmitt Industries beats Telesis Bio on 6 of the 10 factors compared between the two stocks.

Get Telesis Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TBIO vs. The Competition

MetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$21,000.00$4.30B$5.35B$8.38B
Dividend YieldN/A0.57%5.22%4.10%
P/E Ratio0.0026.5826.8419.71
Price / Sales0.003.74391.39116.98
Price / CashN/A36.2338.2534.62
Price / Book0.081.536.794.50
Net Income-$47.72M-$84.30M$3.23B$248.18M
7 Day PerformanceN/A2.97%4.07%1.14%
1 Month PerformanceN/A6.67%12.52%15.20%
1 Year PerformanceN/A-24.24%16.83%6.56%

Telesis Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TBIO
Telesis Bio
N/A$0.01
flat
N/A-99.7%$21,000.00$225.09M0.00200Upcoming Earnings
SMIT
Schmitt Industries
N/A$0.02
flat
N/AN/A$72,000.00$9.89M0.00160
SPEC
Spectaire
N/A$0.00
flat
N/A-99.5%$20,000.00N/A0.008
THMO
ThermoGenesis
N/AN/AN/A-100.0%$1,000.00$9.61M0.0040
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37M0.0090
OLITW
OmniLit Acquisition
N/A$0.05
+1.9%
N/A-75.4%$0.00N/A0.003Gap Down
High Trading Volume
PRENW
Prenetics Global
N/A$0.01
-1.0%
N/A+32.0%$0.00$30.62M0.001Positive News
Gap Down
QSIAW
Quantum-Si
N/A$0.50
+6.5%
N/A+333.3%$0.00$3.06M0.00150Positive News
SMAPW
SportsMap Tech Acquisition
N/A$0.05
flat
N/A-16.7%$0.00N/A0.00N/A
TT
Trane Technologies
4.0979 of 5 stars
$416.55
+2.9%
$421.07
+1.1%
+29.9%$92.90B$20.31B37.0339,000Positive News
KEYS
Keysight Technologies
4.0696 of 5 stars
$162.61
+5.5%
$181.33
+11.5%
+1.6%$28.10B$5.02B46.4615,000Trending News
Earnings Report
Analyst Forecast
Gap Up

Related Companies and Tools


This page (NASDAQ:TBIO) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners